APO Research
Talk to an analyst

APO RESEARCH · REPORT

Typhoid Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Typhoid Vaccine Industry Growth and Trends Forecast to 2032

26 December 202591 pages

Choose your research edition.

Industry ResearchTyphoid Vaccine Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Typhoid Vaccine Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Typhoid Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Typhoid Vaccine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Typhoid Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Typhoid Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Typhoid Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Typhoid Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Typhoid Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Typhoid Vaccine include Actiza Pharmaceutical, Bharat Biotec, Merit Pharmaceuticals, PaxVax, GlaxoSmithKline, Merck and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Typhoid Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Typhoid Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Typhoid Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Typhoid Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Typhoid Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Typhoid Vaccine Market by Company

Actiza Pharmaceutical

Bharat Biotec

Merit Pharmaceuticals

PaxVax

GlaxoSmithKline

Merck

Sanofi

Typhoid Vaccine Segment by Type

Oral Type Typhoid Vaccine

Injection Type Typhoid Vaccine

Typhoid Vaccine Segment by Application

Pharmaceutical & Biotechnology Companies

Hospital

Research & Academic Laboratories

Others

Typhoid Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Typhoid Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Typhoid Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Typhoid Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Typhoid Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Typhoid Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Type Typhoid Vaccine Table 2. Major Company of Injection Type Typhoid Vaccine Table 3. Global Typhoid Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Typhoid Vaccine Sales by Type (2021-2026) & (K Units) Table 5. Global Typhoid Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Typhoid Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Typhoid Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Typhoid Vaccine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Typhoid Vaccine Sales by Type (2027-2032) & (K Units) Table 10. Global Typhoid Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Typhoid Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Typhoid Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Typhoid Vaccine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Typhoid Vaccine Sales by Type (2021-2026) & (K Units) Table 15. North America Typhoid Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Typhoid Vaccine Sales by Type (2021-2026) & (K Units) Table 17. Europe Typhoid Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Typhoid Vaccine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Typhoid Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Typhoid Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Typhoid Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Typhoid Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Typhoid Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Typhoid Vaccine Industry Trends Table 25. Typhoid Vaccine Industry Drivers Table 26. Typhoid Vaccine Industry Opportunities and Challenges Table 27. Typhoid Vaccine Industry Restraints Table 28. Global Typhoid Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Typhoid Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Typhoid Vaccine Sales by Company (2021-2026) & (K Units) Table 31. Global Typhoid Vaccine Sales Share by Company (2021-2026) Table 32. Global Typhoid Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Typhoid Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Typhoid Vaccine Major Company Production Sites and Headquarters Table 35. Global Typhoid Vaccine Company, Product Type & Application Table 36. Global Typhoid Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Typhoid Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Typhoid Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Typhoid Vaccine Sales by Region (2021-2026) & (K Units) Table 41. Global Typhoid Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Typhoid Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Typhoid Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Typhoid Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Typhoid Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global Typhoid Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Typhoid Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Typhoid Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Typhoid Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Typhoid Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Typhoid Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global Typhoid Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Typhoid Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Typhoid Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Typhoid Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Typhoid Vaccine Sales by Application (2027-2032) & (K Units) Table 57. Global Typhoid Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Typhoid Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Typhoid Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Typhoid Vaccine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Typhoid Vaccine Sales by Application (2021-2026) & (K Units) Table 62. North America Typhoid Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Typhoid Vaccine Sales by Application (2021-2026) & (K Units) Table 64. Europe Typhoid Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Typhoid Vaccine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Typhoid Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Typhoid Vaccine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Typhoid Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Typhoid Vaccine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Typhoid Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Actiza Pharmaceutical Company Information Table 72. Actiza Pharmaceutical Business Overview Table 73. Actiza Pharmaceutical Typhoid Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Actiza Pharmaceutical Typhoid Vaccine Product Portfolio Table 75. Actiza Pharmaceutical Recent Development Table 76. Bharat Biotec Company Information Table 77. Bharat Biotec Business Overview Table 78. Bharat Biotec Typhoid Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Bharat Biotec Typhoid Vaccine Product Portfolio Table 80. Bharat Biotec Recent Development Table 81. Merit Pharmaceuticals Company Information Table 82. Merit Pharmaceuticals Business Overview Table 83. Merit Pharmaceuticals Typhoid Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Merit Pharmaceuticals Typhoid Vaccine Product Portfolio Table 85. Merit Pharmaceuticals Recent Development Table 86. PaxVax Company Information Table 87. PaxVax Business Overview Table 88. PaxVax Typhoid Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. PaxVax Typhoid Vaccine Product Portfolio Table 90. PaxVax Recent Development Table 91. GlaxoSmithKline Company Information Table 92. GlaxoSmithKline Business Overview Table 93. GlaxoSmithKline Typhoid Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. GlaxoSmithKline Typhoid Vaccine Product Portfolio Table 95. GlaxoSmithKline Recent Development Table 96. Merck Company Information Table 97. Merck Business Overview Table 98. Merck Typhoid Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Merck Typhoid Vaccine Product Portfolio Table 100. Merck Recent Development Table 101. Sanofi Company Information Table 102. Sanofi Business Overview Table 103. Sanofi Typhoid Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Sanofi Typhoid Vaccine Product Portfolio Table 105. Sanofi Recent Development Table 106. North America Typhoid Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. North America Typhoid Vaccine Sales by Country (2021-2026) & (K Units) Table 108. North America Typhoid Vaccine Sales Market Share by Country (2021-2026) Table 109. North America Typhoid Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 110. North America Typhoid Vaccine Sales Market Share Forecast by Country (2027-2032) Table 111. North America Typhoid Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Typhoid Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Typhoid Vaccine Market Share by Country (2021-2026) Table 114. North America Typhoid Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Typhoid Vaccine Market Share Forecast by Country (2027-2032) Table 116. Europe Typhoid Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Europe Typhoid Vaccine Sales by Country (2021-2026) & (K Units) Table 118. Europe Typhoid Vaccine Sales Market Share by Country (2021-2026) Table 119. Europe Typhoid Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 120. Europe Typhoid Vaccine Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Typhoid Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Typhoid Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Typhoid Vaccine Market Share by Country (2021-2026) Table 124. Europe Typhoid Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Typhoid Vaccine Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Typhoid Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Typhoid Vaccine Sales by Country (2021-2026) & (K Units) Table 128. Asia-Pacific Typhoid Vaccine Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Typhoid Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 130. Asia-Pacific Typhoid Vaccine Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Typhoid Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Typhoid Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Typhoid Vaccine Market Share by Country (2021-2026) Table 134. Asia-Pacific Typhoid Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Typhoid Vaccine Market Share Forecast by Country (2027-2032) Table 136. Latin America Typhoid Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Latin America Typhoid Vaccine Sales by Country (2021-2026) & (K Units) Table 138. Latin America Typhoid Vaccine Sales Market Share by Country (2021-2026) Table 139. Latin America Typhoid Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 140. Latin America Typhoid Vaccine Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Typhoid Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Typhoid Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Typhoid Vaccine Market Share by Country (2021-2026) Table 144. Latin America Typhoid Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Typhoid Vaccine Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Typhoid Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Typhoid Vaccine Sales by Country (2021-2026) & (K Units) Table 148. Middle East and Africa Typhoid Vaccine Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Typhoid Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 150. Middle East and Africa Typhoid Vaccine Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Typhoid Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Typhoid Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Typhoid Vaccine Market Share by Country (2021-2026) Table 154. Middle East and Africa Typhoid Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Typhoid Vaccine Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Typhoid Vaccine Distributors List Table 159. Typhoid Vaccine Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Typhoid Vaccine Image Figure 2. Global Typhoid Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Typhoid Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Typhoid Vaccine Sales (2021-2032) & (K Units) Figure 5. Oral Type Typhoid Vaccine Image Figure 6. Global Oral Type Typhoid Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Injection Type Typhoid Vaccine Image Figure 8. Global Injection Type Typhoid Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Typhoid Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Typhoid Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Typhoid Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Typhoid Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Typhoid Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Typhoid Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Typhoid Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Typhoid Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Typhoid Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Typhoid Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Typhoid Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Typhoid Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Typhoid Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Pharmaceutical & Biotechnology Companies Image Figure 24. Global Pharmaceutical & Biotechnology Companies Sales YoY Growth (2021-2032) & (K Units) Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Research & Academic Laboratories Image Figure 28. Global Research & Academic Laboratories Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Typhoid Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Typhoid Vaccine Market Share by Application 2025 VS 2032 Figure 33. North America Typhoid Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. North America Typhoid Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Europe Typhoid Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Europe Typhoid Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Typhoid Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Typhoid Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Latin America Typhoid Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Typhoid Vaccine Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Typhoid Vaccine Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Typhoid Vaccine Sales Market Share in Value by Application in 2025 Figure 43. North America Typhoid Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Typhoid Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Typhoid Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Typhoid Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Typhoid Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Typhoid Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Typhoid Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Typhoid Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Typhoid Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Typhoid Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Typhoid Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Typhoid Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Typhoid Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Typhoid Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Typhoid Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Typhoid Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Typhoid Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Typhoid Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Typhoid Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Typhoid Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Typhoid Vaccine Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Typhoid Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Type Typhoid Vaccine
  • Injection Type Typhoid Vaccine
Applications
  • Pharmaceutical & Biotechnology Companies
  • Hospital
  • Research & Academic Laboratories
  • Others
Companies covered
  • Actiza Pharmaceutical
  • Bharat Biotec
  • Merit Pharmaceuticals
  • PaxVax
  • GlaxoSmithKline
  • Merck
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Typhoid Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Typhoid Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Typhoid Vaccine Market by Type
  6. 1.3.1 Oral Type Typhoid Vaccine
  7. 1.3.2 Injection Type Typhoid Vaccine
  8. 1.4 Global Typhoid Vaccine Market Size by Type
  9. 1.4.1 Global Typhoid Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Typhoid Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Typhoid Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Typhoid Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Typhoid Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Typhoid Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Typhoid Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Typhoid Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Typhoid Vaccine Industry Trends
  2. 2.2 Typhoid Vaccine Industry Drivers
  3. 2.3 Typhoid Vaccine Industry Opportunities and Challenges
  4. 2.4 Typhoid Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Typhoid Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Typhoid Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Typhoid Vaccine Price (2021-2026)
  4. 3.4 Global Typhoid Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Typhoid Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Typhoid Vaccine Company, Product Type & Application
  7. 3.7 Global Typhoid Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Typhoid Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Typhoid Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Typhoid Vaccine Tier 1, Tier 2, and Tier 3
4 Typhoid Vaccine Regional Status and Outlook
  1. 4.1 Global Typhoid Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Typhoid Vaccine Historic Market Size by Region
  3. 4.2.1 Global Typhoid Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Typhoid Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Typhoid Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Typhoid Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Typhoid Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Typhoid Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Typhoid Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Typhoid Vaccine by Application
  1. 5.1 Typhoid Vaccine Market by Application
  2. 5.1.1 Pharmaceutical & Biotechnology Companies
  3. 5.1.2 Hospital
  4. 5.1.3 Research & Academic Laboratories
  5. 5.1.4 Others
  6. 5.2 Global Typhoid Vaccine Market Size by Application
  7. 5.2.1 Global Typhoid Vaccine Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Typhoid Vaccine Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Typhoid Vaccine Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Typhoid Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Typhoid Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Typhoid Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Typhoid Vaccine Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Typhoid Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Actiza Pharmaceutical
  2. 6.1.1 Actiza Pharmaceutical Company Information
  3. 6.1.2 Actiza Pharmaceutical Business Overview
  4. 6.1.3 Actiza Pharmaceutical Typhoid Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Actiza Pharmaceutical Typhoid Vaccine Product Portfolio
  6. 6.1.5 Actiza Pharmaceutical Recent Developments
  7. 6.2 Bharat Biotec
  8. 6.2.1 Bharat Biotec Company Information
  9. 6.2.2 Bharat Biotec Business Overview
  10. 6.2.3 Bharat Biotec Typhoid Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bharat Biotec Typhoid Vaccine Product Portfolio
  12. 6.2.5 Bharat Biotec Recent Developments
  13. 6.3 Merit Pharmaceuticals
  14. 6.3.1 Merit Pharmaceuticals Company Information
  15. 6.3.2 Merit Pharmaceuticals Business Overview
  16. 6.3.3 Merit Pharmaceuticals Typhoid Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merit Pharmaceuticals Typhoid Vaccine Product Portfolio
  18. 6.3.5 Merit Pharmaceuticals Recent Developments
  19. 6.4 PaxVax
  20. 6.4.1 PaxVax Company Information
  21. 6.4.2 PaxVax Business Overview
  22. 6.4.3 PaxVax Typhoid Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 PaxVax Typhoid Vaccine Product Portfolio
  24. 6.4.5 PaxVax Recent Developments
  25. 6.5 GlaxoSmithKline
  26. 6.5.1 GlaxoSmithKline Company Information
  27. 6.5.2 GlaxoSmithKline Business Overview
  28. 6.5.3 GlaxoSmithKline Typhoid Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 GlaxoSmithKline Typhoid Vaccine Product Portfolio
  30. 6.5.5 GlaxoSmithKline Recent Developments
  31. 6.6 Merck
  32. 6.6.1 Merck Company Information
  33. 6.6.2 Merck Business Overview
  34. 6.6.3 Merck Typhoid Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Merck Typhoid Vaccine Product Portfolio
  36. 6.6.5 Merck Recent Developments
  37. 6.7 Sanofi
  38. 6.7.1 Sanofi Company Information
  39. 6.7.2 Sanofi Business Overview
  40. 6.7.3 Sanofi Typhoid Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sanofi Typhoid Vaccine Product Portfolio
  42. 6.7.5 Sanofi Recent Developments
7 North America by Country
  1. 7.1 North America Typhoid Vaccine Sales by Country
  2. 7.1.1 North America Typhoid Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Typhoid Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Typhoid Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Typhoid Vaccine Market Size by Country
  6. 7.2.1 North America Typhoid Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Typhoid Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Typhoid Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Typhoid Vaccine Sales by Country
  2. 8.1.1 Europe Typhoid Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Typhoid Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Typhoid Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Typhoid Vaccine Market Size by Country
  6. 8.2.1 Europe Typhoid Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Typhoid Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Typhoid Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Typhoid Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Typhoid Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Typhoid Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Typhoid Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Typhoid Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Typhoid Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Typhoid Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Typhoid Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Typhoid Vaccine Sales by Country
  2. 10.1.1 South America Typhoid Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Typhoid Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Typhoid Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Typhoid Vaccine Market Size by Country
  6. 10.2.1 South America Typhoid Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Typhoid Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Typhoid Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Typhoid Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Typhoid Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Typhoid Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Typhoid Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Typhoid Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Typhoid Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Typhoid Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Typhoid Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Typhoid Vaccine Value Chain Analysis
  2. 12.1.1 Typhoid Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Typhoid Vaccine Production Mode & Process
  7. 12.2 Typhoid Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Typhoid Vaccine Distributors
  10. 12.2.3 Typhoid Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst